Page 17 - Shankar Musunuri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ocugen, Inc (NASDAQ:OCGN) Q4 2022 Earnings Call Transcript

Operator: Good morning and welcome to Ocugen s Fourth Quarter and Full Year 2022 Financial Results and Business Update Call. Please note that this call is being recorded at this time.

Uttar pradeshUnited statesJessica crespoShankar musunuriKuan wuJennifer kimJonathan aschoffOcugen head of corporate communicationsCantor fitzgeraldDrug administrationOcugen incCall transcript februaryFourth quarterFull yearBusiness updateTiffany hamilton

Why Ocugen Stock Eked Out a Win Today

The company is clearly progressing on several fronts with its pipeline programs.

Shankar musunuriDrug administrationInvestigational new drug

Ocugen (OCGN) Q4 2022 Earnings Call Transcript

OCGN earnings call for the period ending December 31, 2022.

United statesJess crespoQuan vuDaniil gataulinJennifer kimRobert leboyerJessica crespoSean leeDaniil gataulin chardanShankar musunuriJen kim cantor fitzgeraldJonathan aschoffCantor fitzgeraldDrug administrationTiffany hamilton head of corporate communicationsCompany analyst

Bharat Biotech s partner says Covaxin shows positive results in Phase 2/3 study in US

Ocugen (OCGN) Reports Positive Phase 2/3 Top-Line Data for COVAXIN

Ocugen (OCGN) Reports Positive Phase 2/3 Top-Line Data for COVAXIN
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshShankar musunuriStates clinicaltrialsEric feiglHealth economist for microclinic internationalNational institute of virologyWorld health organizationEngland complex systems instituteIndian council of medical researchTiffany hamiltonhead of communicationsExchange commissionFounder of the world health networkBharat biotechbharat biotech internationalBharat biotech international limitedOcugen inc